Launches Revolutionary Treatment for Numerous Medical Conditions

According to the Health and Safety Executive, more than 1 million adults currently suffer from COPD in Great Britain alone; furthermore, the American Lung Association reports an estimated 13 million individuals suffering from the condition in the United States. While some respond well to traditional oxygen, steroid supplements and inhaled albuterol treatments for improved breathing, many see little improvement in their condition. These conventional treatments also offer no help for the extreme fatigue, headaches and other symptoms accompanying the disease.